Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immune biomarkers and response to checkpoint inhibition of BRAF^V600 and BRAF non-V600 altered lung cancers.

Autor: Murciano-Goroff, Yonina R., Pak, Terry, Mondaca, Sebastian, Flynn, Jessica R., Montecalvo, Joseph, Rekhtman, Natasha, Halpenny, Darragh, Plodkowski, Andrew J., Wu, Stephanie L., Kris, Mark G., Paik, Paul K., Riely, Gregory J., Yu, Helena A., Rudin, Charles M., Hellmann, Matthew D., Land, Josiah D., Buie, Larry W., Heller, Glenn, Lito, Piro, Yaeger, Rona

Publikováno v: British Journal of Cancer; Apr2022, Vol. 126 Issue 6, p889-898, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immune biomarkers and response to checkpoint inhibition of BRAF ^V600 and BRAF non-V600 altered lung cancers.

Autor: Murciano-Goroff YR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pak T; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mondaca S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Flynn JR; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Montecalvo J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rekhtman N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Halpenny D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu SL; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Paik PK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yu HA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Land JD; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Buie LW; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Heller G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lito P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Liu D; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Offin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. offinm@mskcc.org.

Publikováno v: British journal of cancer [Br J Cancer] 2022 Apr; Vol. 126 (6), pp. 889-898. Date of Electronic Publication: 2021 Dec 28.